Chugai Pharmaceutical Co Ltd - Company Profile
Powered by 
All the data and insights you need on Chugai Pharmaceutical Co Ltd in one report.
$295
- Save hours of research time and resources with
our up-to-date Chugai Pharmaceutical Co Ltd Strategy Report
- Understand Chugai Pharmaceutical Co Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on Chugai Pharmaceutical Co Ltd’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
| Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
|---|---|---|---|---|
| 22 Aug 2022 | Chugai Pharma Enters into Licensing Agreement with Noile-Immune Biotech | Licensing Agreement |
Chugai Pharmaceutical Co Ltd
|
Noile-Immune Biotech Inc
|
| 24 Mar 2022 | Chugai Pharma Enters into Licensing Agreement with Halozyme Therapeutics | Licensing Agreement |
Chugai Pharmaceutical Co Ltd
|
Halozyme Therapeutics Inc |
| 09 Jul 2021 | Alebund Pharma Enters into Option and License Agreement with Chugai Pharma | Licensing Agreement |
Shanghai Alebund Pharmaceuticals Ltd
|
Chugai Pharmaceutical Co Ltd |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer